-
Je něco špatně v tomto záznamu ?
The prognostic impact of renal function decline during hospitalization for myocardial infarction
O. Mayer, J. Seidlerová, J. Bruthans, J. Opatrný, M. Hromádka, J. Jirák, J. Filipovský
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
PubMed Central
od 2015
ProQuest Central
od 2019-01-01 do 2021-04-30
Health & Medicine (ProQuest)
od 2019-01-01 do 2021-04-30
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
33541131
DOI
10.2217/cer-2020-0085
Knihovny.cz E-zdroje
- MeSH
- hodnoty glomerulární filtrace MeSH
- hospitalizace MeSH
- infarkt myokardu * epidemiologie MeSH
- lidé MeSH
- prognóza MeSH
- renální insuficience * epidemiologie MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Aim: We analyzed the mortality risk of myocardial infarction (MI) patients according to renal function, observed during hospitalization. Materials & methods: Patients hospitalized for MI between 2006 and 2018 were followed (n = 5659). We divided the sample into four groups by estimated glomerular filtration (eGFR) [ml/min]: normal functions (lowest eGFR during hospitalization >60); transiently moderate insufficiency (lowest eGFR >30 and ≤60, highest >60); permanently moderate insufficiency (highest eGFR >30 and ≤60); severe insufficiency (highest and lowest eGFR ≤30). Results: Permanently moderate renal insufficiency indicates increased 5-years all-cause mortality (hazard risk ratio: 2.27 [95% CIs: 1.87-2.75], p < 0.0001), but a similar risk was found in patients with the only transient decline of renal functions (hazard risk ratio: 2.08 [95% CIs: 1.70-2.55], p < 0.0001). Both moderate insufficiency subgroups (transient/permanent) did not statistically differ regarding mortality risk. Conclusion: Even just fluctuation of eGFR toward moderate insufficiency during hospitalization represents an important prognostic indicator in MI patients.
Biomedical Center Medical Faculty of Charles University Pilsen Czech Republic
Department of Informatics University Hospital Pilsen Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019342
- 003
- CZ-PrNML
- 005
- 20210830100919.0
- 007
- ta
- 008
- 210728s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2217/cer-2020-0085 $2 doi
- 035 __
- $a (PubMed)33541131
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Mayer, Otto $u 2nd Department of Internal Medicine, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic $u Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
- 245 14
- $a The prognostic impact of renal function decline during hospitalization for myocardial infarction / $c O. Mayer, J. Seidlerová, J. Bruthans, J. Opatrný, M. Hromádka, J. Jirák, J. Filipovský
- 520 9_
- $a Aim: We analyzed the mortality risk of myocardial infarction (MI) patients according to renal function, observed during hospitalization. Materials & methods: Patients hospitalized for MI between 2006 and 2018 were followed (n = 5659). We divided the sample into four groups by estimated glomerular filtration (eGFR) [ml/min]: normal functions (lowest eGFR during hospitalization >60); transiently moderate insufficiency (lowest eGFR >30 and ≤60, highest >60); permanently moderate insufficiency (highest eGFR >30 and ≤60); severe insufficiency (highest and lowest eGFR ≤30). Results: Permanently moderate renal insufficiency indicates increased 5-years all-cause mortality (hazard risk ratio: 2.27 [95% CIs: 1.87-2.75], p < 0.0001), but a similar risk was found in patients with the only transient decline of renal functions (hazard risk ratio: 2.08 [95% CIs: 1.70-2.55], p < 0.0001). Both moderate insufficiency subgroups (transient/permanent) did not statistically differ regarding mortality risk. Conclusion: Even just fluctuation of eGFR toward moderate insufficiency during hospitalization represents an important prognostic indicator in MI patients.
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a infarkt myokardu $x epidemiologie $7 D009203
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a renální insuficience $x epidemiologie $7 D051437
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Seidlerová, Jitka $u 2nd Department of Internal Medicine, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic $u Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
- 700 1_
- $a Bruthans, Jan $u 2nd Department of Internal Medicine, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic $u Centre for Cardiovascular Prevention, First Faculty of Medicine, Charles, University & Thomayer's Hospital, Prague, Czech Republic
- 700 1_
- $a Opatrný, Jan $u Department of Cardiology, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic
- 700 1_
- $a Hromádka, Milan $u Department of Cardiology, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic
- 700 1_
- $a Jirák, Josef $u Department of Informatics, University Hospital, Pilsen, Czech Republic
- 700 1_
- $a Filipovský, Jan $u 2nd Department of Internal Medicine, Medical Faculty of Charles University & University Hospital, Pilsen, Czech Republic $u Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
- 773 0_
- $w MED00195023 $t Journal of comparative effectiveness research $x 2042-6313 $g Roč. 10, č. 3 (2021), s. 219-228
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33541131 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100919 $b ABA008
- 999 __
- $a ok $b bmc $g 1690217 $s 1139788
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 10 $c 3 $d 219-228 $e 20210205 $i 2042-6313 $m Journal of comparative effectiveness research $n J Comp Eff Res $x MED00195023
- LZP __
- $a Pubmed-20210728